DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Udell JA, Bhatt DL, Braunwald E. et al.
Investigators Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial.
Diabetes Care 2015;
38: 696-705
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.